Activation of Notch signaling in human colon adenocarcinoma

International Journal of Oncology

Volumn 33, Issue 6, 2008, Pages 1223-1229

  Reedijk, Michael ^a,b   Odorcic, Silvia ^a   Zhang, Hui ^a   Chetty, Runjan ^c   Tennert, Carsten ^d   Dickson, Brendan C ^e   Lockwood, Gina ^b   Gallinger, Steven ^f   Egan, Sean E ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e MOUNT SINAI HOSPITAL   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Colon cancer; Hes1; Notch; Prognosis; Signaling

Indexed keywords

JAGGED1; MEMBRANE PROTEIN; MESSENGER RNA; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN LFNG; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CALCIUM BINDING PROTEIN; GLYCOSYLTRANSFERASE; HES1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; LFNG PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ARTICLE; CANCER SURVIVAL; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; ADENOCARCINOMA; CANADA; CELL DIFFERENTIATION; CLINICAL TRIAL; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; GERMANY; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; REGISTER;

ADENOCARCINOMA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CALCIUM-BINDING PROTEINS; CELL DIFFERENTIATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GERMANY; GLYCOSYLTRANSFERASES; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MEMBRANE PROTEINS; ONTARIO; PROGNOSIS; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; REGISTRIES; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 59049088446     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000112     Document Type: Article

References (37)

1. Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin 52: 23-47, 2002.
2. Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med 10: 789-799, 2004.
3. Gregorieff A and Clevers H: Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19: 877-890, 2005.
4. Dove WF, Cormier RT, Gould KA, Halberg RB, Merritt AJ, Newton MA and Shoemaker AR: The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos Trans R Soc Lond B Biol Sci 353: 915-923, 1998.
5. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T and Clevers H: Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111: 251-263, 2002.
6. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S and Clevers H: EphB receptor activity suppresses colorectal cancer progression. Nature 435: 1126-1130, 2005.
7. Van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F and Clevers H: Notch/ gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435: 959-963, 2005.
8. Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284: 770-776, 1999.
9. Callahan R and Egan SE: Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 9: 145-163, 2004.
10. Chiba S: Notch signaling in stem cell systems. Stem Cells 24: 2437-2447, 2006.
11. Haines N and Irvine KD: Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol 4: 786-797, 2003.
12. Cohen B, Bashirullah A, Dagnino L, Campbell C, Fisher WW, Leow CC, Whiting E, Ryan D, Zinyk D, Boulianne G, Hui CC, Gallie B, Phillips RA, Lipshitz HD and Egan SE: Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nat Genet 16: 283-288, 1997.
13. Johnston SH, Rauskolb C, Wilson R, Prabhakaran B, Irvine KD and Vogt TF: A family of mammalian fringe genes implicated in boundary determination and the Notch pathway. Development 124: 2245-2254, 1997.
14. Kopan R: Notch: a membrane-bound transcription factor. J Cell Sci 115: 1095-1097, 2002.
15. Hayward P, Kalmar T and Martinez Arias A: Wnt/Notch signalling and information processing during development. Development 135: 411-424, 2008.
16. Gridley T: The long and short of it: somite formation in mice. Dev Dyn 235: 2330-2336, 2006.
17. Yang Q, Bermingham NA, Finegold MJ and Zoghbi HY: Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294: 2155-2158, 2001.
18. Riccio O, van Gijn ME, Bezdek AC, Pellegrinet L, van Es JH, Zimber-Strobl U, Strobl LJ, Honjo T, Clevers H and Radtke F: Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27(Kip1) and p57(Kip2). EMBO Rep (In press).
19. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D and Artavanis-Tsakonas S: Notch signals control the fate of immature progenitor cells in the intestine. Nature 435: 964-968, 2005.
20. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P and Madsen OD: Control of endodermal endocrine development by Hes-1. Nat Genet 24: 36-44, 2000.
21. Stanger BZ, Datar R, Murtaugh LC and Melton DA: Direct regulation of intestinal fate by Notch. Proc Natl Acad Sci USA 102: 12443-12448, 2005.
22. Crosnier C, Vargesson N, Gschmeissner S, Ariza-McNaughton L, Morrison A and Lewis J: Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. Development 132: 1093-1104, 2005.
23. Leow CC, Romero MS, Ross S, Polakis P and Gao WQ: Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res 64: 6050-6057, 2004.
24. Leow CC, Polakis P and Gao WQ: A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma. Ann NY Acad Sci 1059: 174-183, 2005.
25. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G and Egan SE: High-level co-expression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537, 2005.
26. Newcomb PA, Baron J, Cotterchio M, et al: Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16: 2331-2343, 2007.
27. Poynter JN, Figueiredo JC, Conti DV, et al: Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res 67: 11128-11132, 2007.
28. Sander GR and Powell BC: Expression of notch receptors and ligands in the adult gut. J Histochem Cytochem 52: 509-516, 2004.
29. Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, Leung SY and Chen X: Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci USA 104: 15418-15423, 2007.
30. Schroder N and Gossler A: Expression of Notch pathway components in fetal and adult mouse small intestine. Gene Expr Patterns 2: 247-250, 2002.
31. Gridley T: Notch signaling in vascular development and physiology. Development 134: 2709-2718, 2007.
32. Vooijs M, Ong CT, Hadland B, Huppert S, Liu Z, Korving J, van den Born M, Stappenbeck T, Wu Y, Clevers H and Kopan R: Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development 134: 535-544, 2007.
33. Veenendaal LM, Kranenburg O, Smakman N, Klomp A, Borel Rinkes IH and van Diest PJ: Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol 30: 1-11, 2008.
34. Dickson BC, Mulligan AM, Zhang H, Lockwood G, O'Malley FP, Egan SE and Reedijk M: High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol 20: 685-693, 2007.
35. Zecchini V, Domaschenz R, Winton D and Jones P: Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev 19: 1686-1691, 2005.
36. Van Es JH and Clevers H: Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11: 496-502, 2005.
37. Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K, Nakashima H, Sato N, Tanaka M and Katano M: Gammasecretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 134: 131-144, 2008.